Glucagon-Like Peptide-1 Receptor Agonists and Pancreatic Cancer Risk in Patients With Type 2 Diabetes
Vertigo from GLP-1 injections can show up as light-headedness, a spinning sensation, or a general feeling of unsteadiness, especially in the first few weeks or after a dose increase of medications like semaglutide (Wegovy) or tirzepatide (Mounjaro)
Samples were tested for the presence of AIs (2-androstenol (5-androst-2-en-17-ol), 2-androstenone (5-androst-2-en-17-one), 3-androstenol (5-androst-3-en-17-ol), 3-androstenone (5-androst-3-en-17-one), 4-androstene-3,6,17 trione (6-oxo), aminoglutethimide, anastrozole, androsta-1,4,6-triene-3,17-dione (androstatrienedione), androsta-3,5-diene-7,17-dione (arimistane), exemestane, formestane, letrozole, and testolactone), and anti-estrogenic substance (bazedoxifene, clomiphene, cyclofenil, fulvestrant, ospemifene, raloxifene, tamoxifen, and toremifene) prohibited by WADA
Availability of data and materials The datasets used and analyzed during the current study are available from the corresponding author on reasonable request
B12 is water-soluble, and excess amounts are simply excreted by the kidneys
Among these, parenteral held a significant share of 63.2%